 |
|
| Blog results | Results 1 - 10 of about 12,545 for avodart for prostate. (0.40 seconds) |
| Sorted by relevance Sort by date |
| Related Blogs: | Avodart - http://channelintegrityrx.com/ | |
| 25 Nov 2009 GlaxoSmithKline (GSK) is withdrawing its sNDA for Avodart (dutasteride) to reduce the risk of developing prostate cancer but plans to resubmit the application with revised data soon. Washington Drug Letter - http://www.fdanews.com/ - References [ More results from Washington Drug Letter ] |
| 25 Nov 2009 by Sitemaster There have been several reports in the past few days that GlaxoSmithKline (GSK) has withdrawn its supplemental New Drug Application (sNDA) for approval to market dutasteride (Avodart) in the US for the prevention of prostate cancer, ... THE "NEW" PROSTATE CANCER INFOLINK - http://prostatecancerinfolink.net/ - References [ More results from THE "NEW" PROSTATE CANCER INFOLINK ] |
| 14 hours ago by Meds AVODART and flomax are medications for the treatment of symptoms of benign prostatic hyperplasia (BPH) in men Avodart weak form of proscar, which can shrink the prostate. This is beneficial for some, but not for others. ... Zillarx - http://www.zillarx.com/ |
| 22 Nov 2009 GlaxoSmithKline (GSK) announced today that in order to provide an update to the application, the company is withdrawing its US Supplemental New Drug Application (sNDA) for Avodart® (dutasteride) for prostate cancer risk reduction among ... All news. - http://www.lifescience-online.com/ |
| 14 Oct 2009 by pillscribe Dutasteride (Avodart) significantly cuts the risk of urinary retention when combined with tamsulosin in men with enlarged prostate, according to GlaxoSmithkline studies. Dutasteride (Avodart) and tamsulosin results show that the ... DWS Pill Scribe - http://www.dancewithshadows.com/pillscribe/ - References |
| 10 Jan 2008 5-alpha-reductase inhibitors, the other class of drugs (such as finasteride [Proscar, Propecia] and dutasteride [Avodart]) help shrink the prostate gland, increasing urinary flow and easing symptoms. These drugs can take from six months ... DukeHealth.org: Health Features - http://www.dukehealth.org/?from=RSS |
| 29 Nov 2009 In April, doctors reported that a large international study had found Avodart, known chemically as dutasteride, reduced chances of men being diagnosed with prostate cancer by 23 percent after four years' use. ... Daily Commercial - http://www.dailycommercial.com/ |
| 30 Nov 2009 Doctors reported in April that a large international study had found that Avodart, which is known chemically as dutasteride, reduces the likelihood of men being diagnosed with prostate cancer by 23% after four years' of use. ... Pharmacy Europe - http://www.pharmacyeurope.net/rss.asp |
| 23 Nov 2009 by AP TRENTON, N.J. — British drugmaker GlaxoSmithKline PLC says it's withdrawing its application for U.S. approval of a drug to prevent prostate cancer. The drug is already sold under the name Avodart, for treating symptoms of an enlarged ... Health News - http://blog.taragana.com/health/ |
| 1 Oct 2009 GlaxoSmithKline (GSK) has filed an sNDA for its drug Avodart to reduce the risk of prostate cancer among men with an increased risk of developing the disease. Drug Industry Daily - http://fdanews.com/ |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
